Strand NGS 3.0 release with processing improvements promise 2x speedup compared to the global benchmarkMarch 31, 2017 | Bangalore, IndiaStrand Life Sciences today announced the release of version 3.0 of its flagship, next-generation sequencing (NGS) data analysis and visualization platform, Strand NGS. Benchmarked against the world’s best, major enhancements in...
Scientists from Strand Life Sciences will demonstrate ‘Strand NGS’, an all-in-one next generation sequencing software at the 67th Annual Meeting of the American Society of Human Genetics (ASHG) to be held from Oct 17 to 21 in Orlando, Florida.Strand is excited to be an exhibitor at ASHG 2017 and...
October 28, 2017 | New Delhi, IndiaStrand Life Sciences, one of India’s foremost bioinformatics and genomic profiling firms, has launched the “Spread Pink. Spread Courage.” campaign this October to raise awareness around Breast Cancer and to commemorate the Breast Cancer Awareness Month. As a part of this campaign, the...
Extension of CAP accreditation following a recent inspection of Strand Centre for Genomics and Personalized Medicine Lab in Bangalore November 21, 2017 | Bangalore, IndiaStrand Life Sciences, India’s leading genomic profiling and bioinformatics company, has been awarded accreditation by the Accreditation Committee of the College of American Pathologists (CAP), an...
Strand Life Sciences today released the findings of their study on Hereditary Breast and Ovarian Cancer Cases in India – Study highlights that BRCA gene mutations are the primary cause of Hereditary Breast and Ovarian Cancer in IndiaJuly 14, 2017 | Bangalore, IndiaStrand Life Sciences, a leader in precision medicine...
Strand LB helps monitor lung, breast, colorectal and other cancers for tumor presence, response, and recurrenceApril 11, 2017 | Bangalore, IndiaAccording to data from the Indian Council of Medical Research (ICMR), India is projected to have 17.3 lakhs new cases of cancer reported in 2020 and over 8.8 lakhs...
